ArticleJournal of inflammation research2024

Preclinical Development of SHR-1819, a Potent Humanized IL-4Rα Antibody for Treating Type 2 Inflammatory Diseases.

Guolin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.